Midaglizole
Alternative Names: DG 5128Latest Information Update: 26 Aug 1994
At a glance
- Originator Daiichi Pharmaceutical
- Developer Nonindustrial source
- Class Antiallergics; Antiasthmatics; Antihyperglycaemics
- Mechanism of Action Alpha 2 adrenergic receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Asthma; Diabetes mellitus